Article

Cost and cost-effectiveness of Hepatitis C virus self-testing in four settings: an economic evaluation

2022-08-09

Abstract excerpt

<h4>Introduction</h4> Globally, there are approximately 58 million people with chronic hepatitis C virus infection (HCV) but only 20% have been diagnosed. HCV self-testing (HCVST) could reach those who have never been tested and increase access and uptake of HCV testing services. We compared cost per HCV diagnosis or cure for HCVST versus facility-based HCV testing services. <h4>Methods</h4> We used a decision ana...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e0df3a2b-5fdf-5125-b7ee-32d88f3e2937
DOI: 10.1101/2022.08.09.22278580

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cost and cost-effectiveness of Hepatitis C virus self-testing in four settings: an economic evaluationDOI 10.1101/2022.08.09.22278580Read

The Cost-effectiveness of One-step Point-of-care Hepatitis C Virus RNA Testing in the United StatesSemantic proximity Read

Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of GeorgiaSemantic proximity Read

The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.Semantic proximity Read

Hepatitis C Core Antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysisSemantic proximity Read

Assessing the potential cost-effectiveness of centralized vs point-of-care testing for hepatitis C virus in Pakistan: a model-based comparisonSemantic proximity Read

Treatment and Cost -outcomes of a simplified antiretroviral treatment strategy for hepatitis C among HCV and HIV co-infected patients in UkraineSemantic proximity Read

Cost effectiveness of hepatitis C direct acting agents.Semantic proximity Read

Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US.Semantic proximity Read

Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea.Semantic proximity Read

Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals.Semantic proximity Read

Hepatitis C Treatment Regimens Are Cost-Effective: But Compared With What?Semantic proximity Read

Interim impact evaluation of the hepatitis C virus elimination program in GeorgiaSemantic proximity Read